Sims Mark E.
SEC insider (Form 3/4/5 filer). CIK 0002139479. Chief Commercial Officer at Candel Therapeutics, Inc. (CADL). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 6, 2026. Located in NEEDHAM, MA.
Companies Sims Mark E. has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Officer, Chief Commercial Officer
Sims Mark E.
CIK: 0002139479
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CADL
Candel Therapeutics, Inc.
Officer